Latest News

© peshkova - © peshkova - stock.adobe.com.
New Site Added to Phase I Trial of Lymphir for the Treatment of B-Cell Lymphoma

April 15th 2024

NCI-designated research and treatment center, City of Hope, in Duarte, CA will participate in UMN’s ongoing Phase I study.

Image credit: David A Litman | stock.adobe.com
Columvi Combination for Diffuse Large B-Cell Lymphoma Achieves Primary Endpoint of Overall Survival in Phase III Trial

April 15th 2024

2024 Trends in Clinical Trials: Q&A With Ken Getz of Tufts and Jim Murphy, CEO of Greenphire
2024 Trends in Clinical Trials: Q&A With Ken Getz of Tufts and Jim Murphy, CEO of Greenphire

April 15th 2024

Image credit: peterschreiber.media | stock.adobe.com
Data From Phase III Extension Trial Show Long-Term Safety, Efficacy of Qulipta in Migraine Prevention

April 12th 2024

© photon_photo - © photon_photo - stock.adobe.com
Taking eCOA Delivery Off the Critical Path to First Patient In

April 12th 2024

Conference Coverage

View All
SCOPE 2024: YPrime CEO, Jim Corrigan Speaks About the Company and Addressing Uncertainty in Clinical Trials
SCOPE 2024: YPrime CEO, Jim Corrigan Speaks About the Company and Addressing Uncertainty in Clinical Trials

February 19th 2024

SCOPE 2024: Alex Deyle of Flatiron Health Discusses RWD in Clinical Trials
SCOPE 2024: Alex Deyle of Flatiron Health Discusses RWD in Clinical Trials

February 14th 2024

SCOPE 2024: Steve Young of CluePoints Discusses RBQM and Key Risk Indicators
SCOPE 2024: Steve Young of CluePoints Discusses RBQM and Key Risk Indicators

February 13th 2024

SCOPE 2024: Todd Everhart of Signant Health Discusses DCTs and Site Burden
SCOPE 2024: Todd Everhart of Signant Health Discusses DCTs and Site Burden

February 13th 2024

Latest Videos
Podcasts
© Alex from the Rock - © Alex from the Rock - stock.adobe.com
Rinol Alaj, Jaclyn Patterson, Applied Clincial Trials Podcast

All News

© 2024 MJH Life Sciences

All rights reserved.